Delivery Order SPE2DR25D3501-SPE2DR26FL9TU
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, for 20,000 unit vials of Recothrom with a ceiling value of $30,646.93. The contract represents a non-competitive, non-set-aside award with an ultimate completion date of August 1, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for 5,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed price delivery order, valued at $2,094.31, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The contract was...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $16,136.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a topical thrombin product used in surgical hemostasis. Issued on August 22, 2025, with an ultimate completion date of August 25, 2025, this non-set-aside contract represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC SPE2DX) valued at $999,999,999.00 through December...
- The Department of Defense Medical Supply Chain awarded a $27,136.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical and trauma settings. This non-competitive delivery order, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order valued at $2,019.18 to AmerisourceBergen Drug Corp for 20,000 units of Recothrom on December 3, 2025, with completion scheduled for December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $1,335.30 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of 20,000 units of the pharmaceutical product RECOTHROM. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has...
- The Defense Logistics Agency awarded a $4,612.79 delivery order to AmerisourceBergen Drug Corp for 20,000 units of Recothrom spray kits, with a completion date of December 4, 2025. This competitive award, issued on December 3, 2025, utilizes firm fixed pricing and carries no set-aside designation. The order will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters operations. This delivery order is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,513.82 fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a specialty medication. The contract has a period of performance through December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,403.54 firm fixed-price contract is for the delivery of 20,000 unit vials of RECOTHROM, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,154.79 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999,...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9TUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of 20,000 unit vials of Recothrom, a pharmaceutical product used in surgical hemostasis. This competitively awarded, firm fixed-price delivery order has a ceiling value of $3,729.60 and an ultimate completion date of December 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999, which serves as a comprehensive pharmaceutical support vehicle providing a wide range of medications, vaccines, and medical supplies to military healthcare systems globally through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement requirements through its extensive portfolio of delivery orders with the Defense Logistics Agency. As a critical vendor for military and veteran healthcare systems, the company demonstrates capability to meet federal procurement standards through open competition across diverse therapeutic domains. The company's primary federal customer base includes the Defense Health Agency and U.S. Coast Guard, among other government healthcare systems served through flexible contract vehicles that enable efficient pharmaceutical supply chain management across multiple regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 12/1/25 |